Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early anticoagulation with warfarin vs rivaroxaban for new-onset atrial fibrillation after CABG
IRCT20200304046696N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of warfarin and rivaroxaban in Atrial fibrillation (AFib) (2 arms), sponsored by Tehran University of Medical Sciences. Started Apr 2020; status: completed.
02
Drugs
warfarinrivaroxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on IRCT20200304046696N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200304046696N1.